Condition

Schizophrenia (3)

Anxiety Disorders (1)

Dementia (1)

Depression (1)

Psychosomatic Disorders (1)

Schizoaffective Disorders (1)

Schizophrenia and Disorders With Psychotic Features (1)

Overall Status

Completed (2)

Terminated (1)

Phase

n/a (1)

phase 3 (1)

phase 4 (1)

Sponsor

Birte Glenthoj (1)

Hannover Medical School (1)

Technical University of Munich (1)

Collaborator

Copenhagen Hospital Corporation (1)

Glostrup University Hospital, Copenhagen (1)

Hvidovre University Hospital (1)

Janssen-Cilag Ltd. (1)

Rigshospitalet, Denmark (1)

The Danish Medical Research Council (1)

The Novo Nordic Foundation (1)

University of Copenhagen (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

zuclopenthixol

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders Trial in Munich (Olanzapine,

Completed

Schizophrenia
+2 more

Olanzapine
+18 more

Munich, Bavaria, Germany

Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psycho

Oct 10, 2018

Dementia, Depression, Schizophrenia Trial in Germany (Phenobarbital, Phenytoin, Carbamazepine)

Terminated

Dementia
+4 more

Phenobarbital
+96 more

Augsburg, Germany
+4 more

Feb 27, 2018

Schizophrenia Trial in Denmark (zuclopenthixol, risperidone)

Completed

Schizophrenia

zuclopenthixol
risperidone

Copenhagen NV, Denmark
+5 more

Sep 16, 2011